Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
---|---|---|---|---|---|---|
MligTC455_34106 | 703 | 14.65 | Mlig455_044525, Mlig455_062524, Mlig455_068573 | Neo: Irradiation Age: - Region-enriched R5: 1.717/0.00109 |
CACNA2D3 | Mlig455_044525 {REF} {Length: 5598} {Pfam: VWA N-terminal [PF08399.13, score=86.8]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=52.2]; von Willebrand factor type A domain [PF13768.8, score=28.1]; von Willebrand factor type A domain [PF13519.8, score=25.8]; von Willebrand factor type A domain [PF00092.30, score=25.6]; Cache domain [PF02743.20, score=18.5]} {Human: ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=246, Expect=4e-66]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=245, Expect=5e-66]} {Dmel: FBgn0261041, stj, straightjacket, [Score=335, Expect=5e-95]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=192, Expect=3e-49]} {Smed: dd_Smed_v6_8926_0_2, dd_Smed_v6_8926_0_2, [RH, Score=439, Expect=2e-132]} {RNA1509_24478} {RNA1310_1519} {RNA815_308} Mlig455_062524 {REF} {Length: 4806} {Pfam: VWA N-terminal [PF08399.13, score=88.0]; von Willebrand factor type A domain [PF13768.8, score=29.6]; von Willebrand factor type A domain [PF13519.8, score=27.1]; von Willebrand factor type A domain [PF00092.30, score=27.0]; Cache domain [PF02743.20, score=19.6]} {Human: ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=240, Expect=3e-67]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=240, Expect=3e-67]} {Dmel: FBgn0261041, stj, straightjacket, [Score=271, Expect=6e-78]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=192, Expect=4e-51]} {Smed: dd_Smed_v6_8926_0_2, dd_Smed_v6_8926_0_2, [Score=365, Expect=3e-112]} {RNA1509_24478, RNA1509_59648} {RNA1310_1519, RNA1509_59648} {RNA1509_59648, RNA815_308} Mlig455_068573 {REF} {Length: 5408} {Pfam: VWA N-terminal [PF08399.13, score=86.8]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=51.0]; von Willebrand factor type A domain [PF13768.8, score=28.1]; von Willebrand factor type A domain [PF00092.30, score=26.8]; von Willebrand factor type A domain [PF13519.8, score=25.1]; Cache domain [PF02743.20, score=18.3]} {Human: ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=245, Expect=1e-65]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=244, Expect=8e-66]} {Dmel: FBgn0261041, stj, straightjacket, [Score=335, Expect=4e-95]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=192, Expect=2e-49]} {Smed: dd_Smed_v6_8926_0_2, dd_Smed_v6_8926_0_2, [Score=437, Expect=1e-131]} {RNA1509_24478} {RNA1310_1519} {RNA815_308} |
Region | logFC | logCPM | Pvalue | FDR | Specificity |
---|---|---|---|---|---|
RegionR1 | 0.596 | 4.206 | 0.64750 | 1.00000 | |
RegionR2 | 0.639 | 4.206 | 0.32667 | 0.71887 | |
RegionR3 | -0.952 | 4.206 | 0.10010 | 0.55459 | |
RegionR4 | -2.119 | 4.206 | 0.00426 | 0.03211 | |
RegionR5 | 1.717 | 4.206 | 0.00006 | 0.00109 | |
RegionR6 | -0.249 | 4.206 | 0.63087 | 1.00000 | |
RegionR7 | -0.118 | 4.206 | 0.85596 | 1.00000 | |
RegionR8 | 0.486 | 4.206 | 0.45154 | 1.00000 |
Region | logFC | logCPM | PValue | FDR | Specificity |
---|---|---|---|---|---|
RegenerationR1 | -6.494 | 4.206 | 0.16084 | 0.90393 | |
RegenerationR2 | -0.012 | 4.206 | 0.98573 | 1.00000 | |
RegenerationR3 | 0.192 | 4.206 | 0.77871 | 0.97470 | |
RegenerationR4 | 0.749 | 4.206 | 0.32361 | 0.76139 | |
RegenerationR5 | -0.285 | 4.206 | 0.64005 | 0.92699 | |
RegenerationR6 | -0.412 | 4.206 | 0.54665 | 0.83695 | |
RegenerationBL | 0.144 | 4.206 | 0.82833 | 1.00000 | |
RegenerationTP | -0.645 | 4.206 | 0.38611 | 0.81962 |
Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | MligTC455_34106 | 703 | 14.65 | Mlig455_044525, Mlig455_062524, Mlig455_068573 | Neo: Irradiation Age: - Region-enriched R5: 1.717/0.00109 |
CACNA2D3 | 6 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | 1.000 | Mlig455_044525 {REF} {Length: 5598} {Pfam: VWA N-terminal [PF08399.13, score=86.8]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=52.2]; von Willebrand factor type A domain [PF13768.8, score=28.1]; von Willebrand factor type A domain [PF13519.8, score=25.8]; von Willebrand factor type A domain [PF00092.30, score=25.6]; Cache domain [PF02743.20, score=18.5]} {Human: ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=246, Expect=4e-66]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=245, Expect=5e-66]} {Dmel: FBgn0261041, stj, straightjacket, [Score=335, Expect=5e-95]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=192, Expect=3e-49]} {Smed: dd_Smed_v6_8926_0_2, dd_Smed_v6_8926_0_2, [RH, Score=439, Expect=2e-132]} {RNA1509_24478} {RNA1310_1519} {RNA815_308} Mlig455_062524 {REF} {Length: 4806} {Pfam: VWA N-terminal [PF08399.13, score=88.0]; von Willebrand factor type A domain [PF13768.8, score=29.6]; von Willebrand factor type A domain [PF13519.8, score=27.1]; von Willebrand factor type A domain [PF00092.30, score=27.0]; Cache domain [PF02743.20, score=19.6]} {Human: ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=240, Expect=3e-67]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=240, Expect=3e-67]} {Dmel: FBgn0261041, stj, straightjacket, [Score=271, Expect=6e-78]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=192, Expect=4e-51]} {Smed: dd_Smed_v6_8926_0_2, dd_Smed_v6_8926_0_2, [Score=365, Expect=3e-112]} {RNA1509_24478, RNA1509_59648} {RNA1310_1519, RNA1509_59648} {RNA1509_59648, RNA815_308} Mlig455_068573 {REF} {Length: 5408} {Pfam: VWA N-terminal [PF08399.13, score=86.8]; Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=51.0]; von Willebrand factor type A domain [PF13768.8, score=28.1]; von Willebrand factor type A domain [PF00092.30, score=26.8]; von Willebrand factor type A domain [PF13519.8, score=25.1]; Cache domain [PF02743.20, score=18.3]} {Human: ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=245, Expect=1e-65]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=244, Expect=8e-66]} {Dmel: FBgn0261041, stj, straightjacket, [Score=335, Expect=4e-95]} {Celegans: WBGene00006772, unc-36, Voltage-dependent calcium channel unc-36, [Score=192, Expect=2e-49]} {Smed: dd_Smed_v6_8926_0_2, dd_Smed_v6_8926_0_2, [Score=437, Expect=1e-131]} {RNA1509_24478} {RNA1310_1519} {RNA815_308} |
2. | MligTC455_34105 | 236 | 4.91 | Mlig455_058228 | Neo: - Age: Up-Down-Down Region-enriched R5: 1.911/0.00007 |
CACNA2D3 | 5.925 | 0.999 | 0.999 | 0.997 | 0.966 | 0.969 | 0.995 | Mlig455_058228 {REF} {Length: 5769} {Pfam: Neuronal voltage-dependent calcium channel alpha 2acd [PF08473.13, score=40.4]} {Human: ENSG00000157445, CACNA2D3, calcium voltage-gated channel auxiliary subunit alpha2delta 3, [Score=58.9, Expect=1e-08]} {Mouse: ENSMUSG00000021991, Cacna2d3, calcium channel, voltage-dependent, alpha2/delta subunit 3, [Score=60.5, Expect=2e-09]} {Dmel: FBgn0028863, CG4587, [Score=59.3, Expect=4e-09]} {RNA1509_34066} {RNA1310_1125} {RNA815_308} |
3. | MligTC455_48685 | 235 | 4.9 | Mlig455_029936 | Neo: - Age: Down-Up-Down Region-enriched R5: 2.194/0.00270 |
B4GALT4 | 1.747 | - | 0.785 | - | - | - | 0.962 | Mlig455_029936 {REF} {Length: 2172} {TRANSSPLICED} {Pfam: N-terminal region of glycosyl transferase group 7 [PF13733.8, score=107.0]; N-terminal domain of galactosyltransferase [PF02709.16, score=59.1]} {Human: ENSG00000121578, B4GALT4, beta-1,4-galactosyltransferase 4, [Score=161, Expect=5e-46]} {Mouse: ENSMUSG00000022793, B4galt4, UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 4, [Score=155, Expect=4e-44]} {Dmel: FBgn0027538, beta4GalNAcTA, [Score=153, Expect=1e-42]} {Celegans: WBGene00000269, bre-4, Beta-1,4-N-acetylgalactosaminyltransferase bre-4, [Score=157, Expect=2e-44]} {Smed: dd_Smed_v6_9651_0_1, dd_Smed_v6_9651_0_1, [Score=160, Expect=3e-45]} {RNA1509_50662} {RNA1310_19457} {RNA815_4062} |
4. | MligTC455_44697 | 643 | 13.39 | Mlig455_040299 | Neo: Neoblast Age: Down-Up-Up Region-enriched R5: 1.035/0.03322 |
METTL14 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_040299 {REF} {Length: 1906} {TRANSSPLICED} {Pfam: MT-A70 [PF05063.16, score=176.6]} {Human: ENSG00000145388, METTL14, methyltransferase like 14, [RH, Score=427, Expect=8e-145]} {Mouse: ENSMUSG00000028114, Mettl14, methyltransferase like 14, [RH, Score=425, Expect=3e-144]} {Dmel: FBgn0032016, Mettl14, Methyltransferase like 14, [RH, Score=414, Expect=5e-141]} {Smed: dd_Smed_v6_6641_0_1, dd_Smed_v6_6641_0_1, [RH, Score=481, Expect=3e-165]} {RNA1509_14222, RNA1509_32101} {RNA1310_14585, RNA1509_32101} {RNA1509_32101, RNA815_3196.1} |
5. | MligTC455_43170 | 206 | 4.3 | Mlig455_044050 | Neo: - Age: Down-Up-Down, logFC(26M/2M)=-0.754 Region-enriched R8: 2.917/0.04703 |
RNF41 | 0.956 | - | - | - | 0.956 | - | - | Mlig455_044050 {REF} {Length: 3399} {Pfam: Zinc finger, C3HC4 type (RING finger) [PF13923.8, score=42.9]; Zinc finger, C3HC4 type (RING finger) [PF00097.27, score=35.9]; Ring finger domain [PF13639.8, score=33.6]; Zinc finger, C3HC4 type (RING finger) [PF13920.8, score=31.6]; RING-type zinc-finger [PF13445.8, score=27.1]; zinc finger of C3HC4-type, RING [PF15227.8, score=25.5]; RING-H2 zinc finger domain [PF12678.9, score=24.6]; TRAF-type zinc finger [PF02176.20, score=24.1]; zinc-RING finger domain [PF14634.8, score=22.6]; Prokaryotic RING finger family 4 [PF14447.8, score=22.0]; Seven in absentia protein family [PF03145.18, score=21.2]; zf-RING of BARD1-type protein [PF14835.8, score=20.1]} {Human: ENSG00000181852, RNF41, ring finger protein 41, [Score=120, Expect=4e-33]} {Mouse: ENSMUSG00000025373, Rnf41, ring finger protein 41, [Score=120, Expect=3e-32]} {Dmel: FBgn0028847, CG9014, [Score=112, Expect=4e-29]} {Smed: dd_Smed_v6_5173_0_1, dd_Smed_v6_5173_0_1, [Score=110, Expect=1e-28]} {RNA1509_36641, RNA1509_49465} {RNA1310_9044.1, RNA1509_49465} {RNA1509_49465, RNA815_14046} |
6. | MligTC455_27278 | 107 | 2.22 | Mlig455_060500 | Neo: - Age: - |
0.95 | - | - | - | - | - | 0.950 | Mlig455_060500 {REF} {Length: 3722} {TRANSSPLICED} {Pfam: FAD dependent oxidoreductase [PF01266.26, score=181.3]; NAD(P)-binding Rossmann-like domain [PF13450.8, score=25.1]; FAD binding domain [PF01494.21, score=21.4]} {Smed: dd_Smed_v6_5776_0_1, dd_Smed_v6_5776_0_1, [Score=238, Expect=3e-75]} {RNA1509_28366} {RNA1310_19914} {RNA815_11518} |